BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 581986)

  • 1. [Bioavailability and importance of the use of multivitamin preparations].
    Heinrich HC
    Arzneimittelforschung; 1978; 28(5):885. PubMed ID: 581986
    [No Abstract]   [Full Text] [Related]  

  • 2. Biopharmaceutical evaluation of ferrous salts in form of oral long-acting tablets.
    Krzyśko K; Bokowski W; Wichliński LM
    Pol J Pharmacol Pharm; 1984; 36(1):73-7. PubMed ID: 6462964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of bioavailability of oral iron preparations.
    Gupta KC; Paul T; Mehta JM; Desai NK; Sanghvi B; Sheth UK
    J Postgrad Med; 1976 Apr; 22(2):94-9. PubMed ID: 802126
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bioavailability of various iron preparations following oral medication].
    Heilmann E; Keim G
    Fortschr Med; 1980 Dec; 98(47-48):1871-4. PubMed ID: 7216093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bioavailability of Ce-Ferro forte. Comparative iron load test (author's transl)].
    Richter E; Schmitt B; Zilly W
    Med Klin; 1978 Aug; 73(34):1171-5. PubMed ID: 683118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of iron in oral ferrous sulfate preparations in healthy volunteers.
    Walker SE; Paton TW; Cowan DH; Manuel MA; Dranitsaris G
    CMAJ; 1989 Sep; 141(6):543-7. PubMed ID: 2776093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Resorption of oral iron preparations].
    Heinrich HC; Führ J
    Med Welt; 1980 Jul; 31(29-30):1104-5. PubMed ID: 7412541
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of multivitamin preparations in pediatrics].
    Huber EG
    Padiatr Padol; 1973; 8(2):232-6. PubMed ID: 4698437
    [No Abstract]   [Full Text] [Related]  

  • 9. Iron in prenatal multivitamin/multimineral supplements. Bioavailability.
    Dawson EB; Dawson R; Behrens J; DeVora MA; McGanity WJ
    J Reprod Med; 1998 Feb; 43(2):133-40. PubMed ID: 9513875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor clinical response to enteric-coated iron preparations.
    Rudinskas L; Paton TW; Walker SE; Dotten DA; Cowan DH
    CMAJ; 1989 Sep; 141(6):565-6. PubMed ID: 2776097
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro evaluation of iron solubility and dialyzability of various iron fortificants and of iron-fortified milk products targeted for infants and toddlers.
    Kapsokefalou M; Alexandropoulou I; Komaitis M; Politis I
    Int J Food Sci Nutr; 2005 Jun; 56(4):293-302. PubMed ID: 16096139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability, absorption mechanism, and toxicity of microencapsulated iron (I) sulfate: studies in mice.
    Boccio JR; Zubillaga MB; Caro RA; Lysionek A; Gotelli CA; Gotelli MJ; Weill R
    Biol Trace Elem Res; 1998; 62(1-2):65-73. PubMed ID: 9630425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral iron therapy in human subjects, comparative absorption between ferrous salts and iron polymaltose.
    Jacobs P; Johnson G; Wood L
    J Med; 1984; 15(5-6):367-77. PubMed ID: 6599114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurements of iron absorption from prenatal multivitamin--mineral supplements.
    Seligman PA; Caskey JH; Frazier JL; Zucker RM; Podell ER; Allen RH
    Obstet Gynecol; 1983 Mar; 61(3):356-62. PubMed ID: 6823378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of vitamins.
    Sauberlich HE
    Prog Food Nutr Sci; 1985; 9(1-2):1-33. PubMed ID: 3911266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigation or oral substitution of iron and folic acid (author's transl)].
    Pietrzik K; Hötzel D
    Int J Vitam Nutr Res; 1980; 50(2):141-9. PubMed ID: 7399810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilized ferrous gluconate as iron source for food fortification: bioavailability and toxicity studies in rats.
    Lysionek AE; Zubillaga MB; Salgueiro MJ; Caro RA; Leonardi NM; Ettlin E; Boccio JR
    Biol Trace Elem Res; 2003 Jul; 94(1):73-8. PubMed ID: 12907829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equivalent bioavailability of iron from ferrous salts and a ferric polymaltose complex. Clinical and experimental studies.
    Jacobs P
    Arzneimittelforschung; 1987 Jan; 37(1A):113-6. PubMed ID: 3566865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examination of Tardyferon depot coated tablet in patients treated by general practitioners.
    Faragó E
    Ther Hung; 1988; 36(2):81-5. PubMed ID: 3201391
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of dose and formulation on iron tolerance in pregnancy.
    Shatrugna V; Raman L; Kailash U; Balakrishna N; Rao KV
    Natl Med J India; 1999; 12(1):18-20. PubMed ID: 10326325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.